EXPERIMENTAL DRUG DEVELOPMENT CENTR EDDC

The Experimental Drug Development Centre (EDDC) is neither a factory nor a trading company. It is a national platform for drug discovery and development in Singapore.

Company Introduction:

The Experimental Drug Development Centre (EDDC) is Singapore's national drug discovery and development platform, established under the Agency for Science, Technology and Research (A*STAR). Its primary mission is to bridge the gap between scientific discoveries and the creation of innovative new medicines. EDDC focuses on the early stages of drug development, including target identification and validation, hit identification, lead optimization, and preclinical drug candidate development. It brings together a multidisciplinary team of scientists, chemists, biologists, and pharmacologists to translate groundbreaking research into potential therapeutic solutions for unmet medical needs. EDDC collaborates extensively with academic institutions, biotechnology companies, and pharmaceutical industry partners both locally and internationally, aiming to accelerate the development of novel drug candidates and foster a vibrant biomedical ecosystem in Singapore. Its work is crucial in advancing healthcare and positioning Singapore as a hub for biomedical innovation.

The Experimental Drug Development Centre (EDDC) in Singapore primarily focuses on early-stage drug discovery and preclinical development. It does not manufacture or sell commercial pharmaceutical products directly to the public or healthcare providers.

Instead, EDDC's contributions and "products" are in the form of:

Drug Candidates and Leads: Compounds and biologics in various stages of preclinical development, intended for further clinical trials and commercialization by pharmaceutical partners.

Therapeutic Platforms and Technologies: Innovative platforms for drug discovery, screening, and target validation.

Intellectual Property: Patents and licenses for novel drug targets, compounds, and therapeutic strategies developed through their research.

Biomarkers and Diagnostic Tools: Research leading to the identification of disease biomarkers and development of early diagnostic assays.

Research Collaborations: Providing expertise and facilities for collaborative drug development projects with academic and industry partners, contributing to the pipeline of future medicines.